Compare IMVT & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | URBN |
|---|---|---|
| Founded | 2018 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.9B |
| IPO Year | 2019 | 1995 |
| Metric | IMVT | URBN |
|---|---|---|
| Price | $24.02 | $61.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $30.78 | ★ $86.91 |
| AVG Volume (30 Days) | 997.2K | ★ 1.8M |
| Earning Date | 02-06-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.67 |
| EPS | N/A | ★ 4.01 |
| Revenue | N/A | ★ $5,550,666,000.00 |
| Revenue This Year | N/A | $10.55 |
| Revenue Next Year | N/A | $6.25 |
| P/E Ratio | ★ N/A | $15.46 |
| Revenue Growth | N/A | ★ 7.71 |
| 52 Week Low | $12.72 | $41.89 |
| 52 Week High | $29.25 | $84.35 |
| Indicator | IMVT | URBN |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 36.62 |
| Support Level | $22.00 | $60.80 |
| Resistance Level | $24.63 | $68.67 |
| Average True Range (ATR) | 1.16 | 2.43 |
| MACD | -0.04 | -0.12 |
| Stochastic Oscillator | 32.41 | 14.79 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.